Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 162

1.

Trends in maternal and neonatal mortality in South Africa: a systematic review protocol.

Damian DJ, Njau B, Lisasi E, Msuya SE, Boulle A.

Syst Rev. 2017 Aug 17;6(1):165. doi: 10.1186/s13643-017-0560-1.

2.

High rates of retention and viral suppression in the scale-up of antiretroviral therapy adherence clubs in Cape Town, South Africa.

Tsondai PR, Wilkinson LS, Grimsrud A, Mdlalo PT, Ullauri A, Boulle A.

J Int AIDS Soc. 2017 Jul 21;20(Suppl 4):51-57. doi: 10.7448/IAS.20.5.21649.

3.

Feasibility of Establishing HIV Case-Based Surveillance to Measure Progress Along the Health Sector Cascade: Situational Assessments in Tanzania, South Africa, and Kenya.

Harklerode R, Schwarcz S, Hargreaves J, Boulle A, Todd J, Xueref S, Rice B.

JMIR Public Health Surveill. 2017 Jul 10;3(3):e44. doi: 10.2196/publichealth.7610.

4.

HIV viral load as an independent risk factor for tuberculosis in South Africa: collaborative analysis of cohort studies.

Fenner L, Atkinson A, Boulle A, Fox MP, Prozesky H, Zürcher K, Ballif M, Furrer H, Zwahlen M, Davies MA, Egger M; International Epidemiology Database to Evaluate AIDS in Southern Africa (IeDEA-SA).

J Int AIDS Soc. 2017 Jun 23;20(1):1-7. doi: 10.7448/IAS.20.1.21327.

5.

Where do HIV-infected adolescents go after transfer? - Tracking transition/transfer of HIV-infected adolescents using linkage of cohort data to a health information system platform.

Davies MA, Tsondai P, Tiffin N, Eley B, Rabie H, Euvrard J, Orrell C, Prozesky H, Wood R, Cogill D, Haas AD, Sohn AH, Boulle A.

J Int AIDS Soc. 2017 May 16;20(Suppl 3):16-24. doi: 10.7448/IAS.20.4.21668.

6.

Changes in estimated glomerular filtration rate over time in South African HIV-1-infected patients receiving tenofovir: a retrospective cohort study.

De Waal R, Cohen K, Fox MP, Stinson K, Maartens G, Boulle A, Igumbor EU, Davies MA.

J Int AIDS Soc. 2017 Apr 10;20(1):1-8. doi: 10.7448/IAS.20.01/21317. Erratum in: J Int AIDS Soc. 2017 Jun 2;20(1):22066.

7.

Diagnostic accuracy, incremental yield and prognostic value of Determine TB-LAM for routine diagnostic testing for tuberculosis in HIV-infected patients requiring acute hospital admission in South Africa: a prospective cohort.

Lawn SD, Kerkhoff AD, Burton R, Schutz C, Boulle A, Vogt M, Gupta-Wright A, Nicol MP, Meintjes G.

BMC Med. 2017 Mar 21;15(1):67. doi: 10.1186/s12916-017-0822-8.

8.

First-line antiretroviral drug discontinuations in children.

Fortuin-de Smidt M, de Waal R, Cohen K, Technau KG, Stinson K, Maartens G, Boulle A, Igumbor EU, Davies MA.

PLoS One. 2017 Feb 13;12(2):e0169762. doi: 10.1371/journal.pone.0169762. eCollection 2017.

9.

Prospects for HIV control in South Africa: a model-based analysis.

Johnson LF, Chiu C, Myer L, Davies MA, Dorrington RE, Bekker LG, Boulle A, Meyer-Rath G.

Glob Health Action. 2016 Jan;9(1):30314. doi: 10.3402/gha.v9.30314.

PMID:
28157035
10.

Severe antiretroviral-associated skin reactions in South African patients: a case series and case-control analysis.

Stewart A, Lehloenya R, Boulle A, de Waal R, Maartens G, Cohen K.

Pharmacoepidemiol Drug Saf. 2016 Nov;25(11):1313-1319. doi: 10.1002/pds.4067. Epub 2016 Jul 27.

PMID:
27464823
11.

Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in single-drug substitutions in first-line antiretroviral therapy for HIV in sub-Saharan Africa?

Brennan AT, Davies MA, Bor J, Wandeler G, Stinson K, Wood R, Prozesky H, Tanser F, Fatti G, Boulle A, Sikazwe I, Wool-Kaloustian K, Yuannoutsos C, Leroy V, de Rekeneire N, Fox MP.

AIDS. 2017 Jan 2;31(1):147-157.

PMID:
27776039
12.

Life expectancy trends in adults on antiretroviral treatment in South Africa.

Johnson LF, Keiser O, Fox MP, Tanser F, Cornell M, Hoffmann CJ, Prozesky H, Boulle A, Davies MA; International Epidemiologic Databases to Evaluate AIDS Southern Africa (IeDEA-SA) Collaboration.

AIDS. 2016 Oct 23;30(16):2545-2550.

13.

Statistical Nature of Atomic Disorder in Irradiated Crystals.

Boulle A, Debelle A.

Phys Rev Lett. 2016 Jun 17;116(24):245501. doi: 10.1103/PhysRevLett.116.245501. Epub 2016 Jun 16.

PMID:
27367393
14.

Prospects for HIV control in South Africa: a model-based analysis.

Johnson LF, Chiu C, Myer L, Davies MA, Dorrington RE, Bekker LG, Boulle A, Meyer-Rath G.

Glob Health Action. 2016 Jun 8;9:30314. doi: 10.3402/gha.v9.30314. eCollection 2016.

15.

Cohort Profile: The Khayelitsha antiretroviral programme, Cape Town, South Africa.

Stinson K, Goemaere E, Coetzee D, van Cutsem G, Hilderbrand K, Osler M, Hennessey C, Wilkinson L, Patten G, Cragg C, Mathee S, Cox V, Boulle A.

Int J Epidemiol. 2017 Apr 1;46(2):e21. doi: 10.1093/ije/dyw057. No abstract available.

PMID:
27208042
16.

The effects of HIV self-testing on the uptake of HIV testing and linkage to antiretroviral treatment among adults in Africa: a systematic review protocol.

Njau B, Damian DJ, Abdullahi L, Boulle A, Mathews C.

Syst Rev. 2016 Apr 5;5:52. doi: 10.1186/s13643-016-0230-8.

17.

Clinician compliance with laboratory monitoring and prescribing guidelines in HIV-1-infected patients receiving tenofovir.

De Waal R, Cohen K, Fox MP, Stinson K, Maartens G, Boulle A, Davies MA.

S Afr Med J. 2016 Mar 9;106(4):52-3. doi: 10.7196/SAMJ.2016.v106i4.10153.

PMID:
27032851
18.

Mortality According to CD4 Count at Start of Combination Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15 Years After Start of Treatment: Collaborative Cohort Study.

May MT, Vehreschild JJ, Trickey A, Obel N, Reiss P, Bonnet F, Mary-Krause M, Samji H, Cavassini M, Gill MJ, Shepherd LC, Crane HM, d'Arminio Monforte A, Burkholder GA, Johnson MM, Sobrino-Vegas P, Domingo P, Zangerle R, Justice AC, Sterling TR, Miró JM, Sterne JAC; Antiretroviral Therapy Cohort Collaboration (ART-CC), Boulle A, Stephan C, Miro JM, Cavassini M, Chêne G, Costagliola D, Dabis F, Monforte AD, Del Amo J, Van Sighem A, Fätkenheuer G, Gill J, Guest J, Haerry DH, Hogg R, Justice A, Shepherd L, Obel N, Crane H, Smith C, Reiss P, Saag M, Sterling T, Teira R, Williams M, Zangerle R, Sterne J, May M, Ingle S, Trickey A.

Clin Infect Dis. 2016 Jun 15;62(12):1571-1577. doi: 10.1093/cid/ciw183. Epub 2016 Mar 29.

19.

Post-treatment effect of isoniazid preventive therapy on tuberculosis incidence in HIV-infected individuals on antiretroviral therapy.

Sumner T, Houben RM, Rangaka MX, Maartens G, Boulle A, Wilkinson RJ, White RG.

AIDS. 2016 May 15;30(8):1279-86. doi: 10.1097/QAD.0000000000001078.

PMID:
26950316
20.

Implementation and Operational Research: Evaluation of a Public-Sector, Provider-Initiated Cryptococcal Antigen Screening and Treatment Program, Western Cape, South Africa.

Vallabhaneni S, Longley N, Smith M, Smith R, Osler M, Kelly N, Cross A, Boulle A, Meintjes G, Govender NP.

J Acquir Immune Defic Syndr. 2016 Jun 1;72(2):e37-e42. doi: 10.1097/QAI.0000000000000976.

Supplemental Content

Loading ...
Support Center